PM Capital’s Pfizer PFE Stock Holding History

PM Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-631,277	Closed	-$26.4M	–	26
2018 Q3	$26.4M	Sell	631,277 -267,485	-30%	-$10.3M	4.52%	14
2018 Q2	$30.9M	Hold	898,762	–	–	5.62%	8
2018 Q1	$30.3M	Buy	898,762 +43,994	+5%	+$1.51M	5.46%	7
2017 Q4	$29.4M	Hold	854,768	–	–	5.27%	9
2017 Q3	$28.9M	Hold	854,768	–	–	5.59%	8
2017 Q2	$27.2M	Hold	854,768	–	–	5.6%	8
2017 Q1	$29.6M	Sell	854,768 -627,287	-42%	-$19.8M	5.82%	6
2016 Q4	$45.6M	Buy	1,482,055 +180,234	+14%	+$5.5M	6.85%	5
2016 Q3	$41.8M	Buy	1,301,821 +24,717	+2%	+$826K	6.73%	5
2016 Q2	$42.7M	Sell	1,277,104 -119,102	-9%	-$3.8M	7.15%	5
2016 Q1	$39.3M	Buy	1,396,206 +32,674	+2%	+$933K	6.59%	6
2015 Q4	$41.8M	Sell	1,363,532 -198,574	-13%	-$6.25M	6.69%	5
2015 Q3	$46.6M	Buy	1,562,106 +63,240	+4%	+$2.03M	8.67%	5
2015 Q2	$47.7M	Buy	1,498,866 +33,306	+2%	+$1.09M	9.32%	4
2015 Q1	$48.4M	Buy	1,465,560 +33,728	+2%	+$1.07M	10.16%	1
2014 Q4	$42.3M	Buy	+1,431,832	New	+$41.1M	10.2%	1

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PM Capital's PFE Position: Q4 2018 in Review

PM Capital sold out of Pfizer (PFE) in Q4 2018, closing a stake of 631,277 shares — an estimated $26.4M sold.

PM Capital first reported a position in PFE in Q4 2014 and held it in 16 quarters. The position peaked at $48.4M in Q1 2015. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

PM Capital reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
PM Capital sold 631,277 Pfizer shares in Q4 2018, an estimated $26.4M.
PM Capital first reported a position in Pfizer in Q4 2014 and held it in 16 quarters.
PM Capital's Pfizer position peaked at $48.4M in Q1 2015.
2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on PM Capital's 13F filing for Q4 2018, filed 3 Jan 2019.